Format

Send to

Choose Destination
Int J Pediatr Otorhinolaryngol. 2005 Jan;69(1):75-80.

Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck.

Author information

1
Department of ENT, Lady Hardinge Medical College and associated Smt. Sucheta Kriplani and Kalawati Saran Children's Hospital, New Delhi 110001, India. nnm@vsnl.com

Abstract

Bleomycin is an established antineoplastic drug, but recently some attempts were made to inject it locally as a sclerosing agent in cases of congenital lymphatic malformations. We present the outcome of this treatment modality tried on 10 paediatric cases of whom 9 had such malformation in the cervical region and one in the parotid region. Seven of these cases had congenital lymphatic malformation while three had haemodynamically less active congenital vascular malformation. All these children were subjected to percutaneous intralesional administration of bleomycin. The size of swelling reduced by 50% or more in seven patients out of which three showed complete or near complete response. There were no major deleterious side effects.

PMID:
15627451
DOI:
10.1016/j.ijporl.2004.08.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center